{"schema_version":"secwatch.filing_event.v1","accession":"0000070318-23-000015","form_type":"8-K","ticker":"THC","cik":"0000070318","company_name":"TENET HEALTHCARE CORP","filed_at":"2023-04-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.959868+00:00","generated_at":"2026-06-16T17:20:28.875621+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Tenet Q1 adj EPS $1.42 rev $5.02B; raises FY23 EBITDA outlook to $3.21-3.41B","bullets":["Q1 net income from continuing ops $143M ($1.32 dil EPS); adj diluted EPS $1.42 vs $1.90 YoY.","Consolidated Adj EBITDA $832M incl $3M grants; ex-grants $829M vs $882M prior.","Ambulatory segment revs +22.6% to $905M; Adj EBITDA ex-grants +21.4% to $340M.","Hospital segment Adj EBITDA ex-grants $402M vs $510M; included $27M cyber insurance proceeds.","FY2023 Adj EBITDA outlook raised to $3.21-3.41B; Q2 outlook Adj EBITDA $765-815M."],"urls":{"canonical":"https://secwatch.observer/filing/0000070318-23-000015","json":"https://secwatch.observer/filing/0000070318-23-000015.json","markdown":"https://secwatch.observer/filing/0000070318-23-000015.md","text":"https://secwatch.observer/filing/0000070318-23-000015.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000015/0000070318-23-000015-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000015/thc-20230425.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-16T17:20:28.875621+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8f93c2881934051c1d2f5d2a7b74301df95ed9c8","claim":"TENET HEALTHCARE CORP reported the quarter ended March 31, 2023 results: revenue $5,021, net income $143 million, EPS $1.32 per diluted share. Guidance raised.","evidence_excerpt":"results for first quarter 2023 versus first quarter 2022 are as follows: Three Months Ended March 31, ($ in millions, except per share results) 2023 2022 Net operating revenues $5,021 $4,745 Net income available to Tenet common shareholders from continuing operations $143 $139 Net income available to Tenet common shareholders from continuing operations per","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/70318/000007031823000015/0000070318-23-000015-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended March 31, 2023"},{"label":"Revenue","value":"$5,021"},{"label":"Net income","value":"$143 million"},{"label":"EPS","value":"$1.32 per diluted share"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}